Ethyl (6-oxopyridazin-1(6H)-yl)acetate, 95.0%, 500mg

2-Cyclobutyl-2-fluoroacetic acid, 1g

4-CHLORO-5-PHENYL-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 100mg

4-(Azetidin-3-yl)morpholine dihydrochloride, 95.0%, 10g

2-Phenyloxetane, 95%, 250mg

Chlorure d'ammonium, min 99,7% pa, qualité ultra, 500 g, emballage plastique.

Acétophénone, min 98%, pour synthèse, 1L, conditionnement verre

2-Amino-6-ethylbenzoic acid, 95.0%, 100mg

4-Bromo-5-chloro-2-nitroaniline, 90.0%, 5g

tert-Butyl (2S,5R)-2-ethyl-5-methylpiperazine-1-carboxylate, 95+%, 1g

2-(4-((3,4-Dichlorobenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

1,1'-(Piperidine-1,4-diyl)bis(2,2,2-trifluoroethan-1-one), 98+%, 5g

7-Bromo-3,4-dihydroquinoxalin-2(1H)-one, 95.0%, 1g